Current and historical daily PE Ratio for AFT Pharmaceuticals Ltd (
ASX:AFP
) from 2015 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. AFT Pharmaceuticals stock (ASX:AFP) PE ratio as of Apr 24 2024 is 30.39.
More Details
AFT Pharmaceuticals Ltd (ASX:AFP) PE Ratio (TTM) Chart
AFT Pharmaceuticals Ltd (ASX:AFP) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1177
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| AFT Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-24 | 29.7 | 2024-02-22 | 33.2 |
| 2024-04-24 | 29.7 | 2024-02-21 | 33.4 |
| 2024-04-23 | 29.7 | 2024-02-20 | 33.4 |
| 2024-04-22 | 28.6 | 2024-02-19 | 33.5 |
| 2024-04-19 | 29.5 | 2024-02-16 | 36.1 |
| 2024-04-18 | 28.2 | 2024-02-15 | 36.6 |
| 2024-04-17 | 28.2 | 2024-02-14 | 36.6 |
| 2024-04-16 | 29.5 | 2024-02-13 | 36.6 |
| 2024-04-15 | 29.7 | 2024-02-12 | 36.3 |
| 2024-04-12 | 29.7 | 2024-02-09 | 36.3 |
| 2024-04-11 | 29.7 | 2024-02-08 | 36.3 |
| 2024-04-10 | 30.2 | 2024-02-07 | 35.0 |
| 2024-04-09 | 31.0 | 2024-02-06 | 35.2 |
| 2024-04-08 | 31.3 | 2024-02-05 | 35.8 |
| 2024-04-05 | 31.3 | 2024-02-02 | 35.0 |
| 2024-04-04 | 31.3 | 2024-02-01 | 34.4 |
| 2024-04-03 | 31.3 | 2024-01-31 | 35.0 |
| 2024-04-02 | 28.8 | 2024-01-30 | 35.0 |
| 2024-04-01 | 28.8 | 2024-01-29 | 35.3 |
| 2024-03-29 | 28.8 | 2024-01-26 | 36.8 |
| 2024-03-28 | 28.8 | 2024-01-25 | 36.8 |
| 2024-03-27 | 30.3 | 2024-01-24 | 36.8 |
| 2024-03-26 | 26.0 | 2024-01-23 | 36.8 |
| 2024-03-25 | 26.0 | 2024-01-22 | 36.7 |
| 2024-03-22 | 28.6 | 2024-01-19 | 36.7 |
| 2024-03-21 | 28.6 | 2024-01-18 | 36.5 |
| 2024-03-20 | 31.0 | 2024-01-17 | 36.5 |
| 2024-03-19 | 31.3 | 2024-01-16 | 36.5 |
| 2024-03-18 | 31.3 | 2024-01-15 | 36.7 |
| 2024-03-15 | 31.3 | 2024-01-12 | 36.7 |
| 2024-03-14 | 31.3 | 2024-01-11 | 36.7 |
| 2024-03-13 | 31.3 | 2024-01-10 | 34.4 |
| 2024-03-12 | 32.3 | 2024-01-09 | 34.4 |
| 2024-03-11 | 29.7 | 2024-01-08 | 33.9 |
| 2024-03-08 | 32.3 | 2024-01-05 | 33.9 |
| 2024-03-07 | 31.8 | 2024-01-04 | 33.9 |
| 2024-03-06 | 31.8 | 2024-01-03 | 33.9 |
| 2024-03-05 | 32.3 | 2024-01-02 | 33.9 |
| 2024-03-04 | 32.3 | 2024-01-01 | 33.9 |
| 2024-03-01 | 32.3 | 2023-12-29 | 33.9 |
| 2024-02-29 | 32.3 | 2023-12-28 | 33.8 |
| 2024-02-28 | 32.3 | 2023-12-27 | 33.8 |
| 2024-02-27 | 32.4 | 2023-12-22 | 33.8 |
| 2024-02-26 | 33.4 | 2023-12-21 | 32.1 |
| 2024-02-23 | 33.2 | 2023-12-20 | 33.9 |
AFT Pharmaceuticals Ltd (ASX:AFP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
AFT Pharmaceuticals Ltd
ISIN : NZAFTE0001S4
Compare
Compare
Traded in other countries / regions
AFT.New ZealandAFP.Australia IPO Date
2015-12-22Description
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers